Literature DB >> 33488950

Oncogenes in high grade serous adenocarcinoma of the ovary.

Pacharla Manasa1, Chirukandath Sidhanth1, Syama Krishnapriya1, Sekar Vasudevan1, Trivadi S Ganesan1.   

Abstract

High grade serous ovarian cancer is characterized by relatively few mutations occurring at low frequency, except in TP53. However other genetic aberrations such as copy number variation alter numerous oncogenes and tumor suppressor genes. Oncogenes are positive regulators of tumorigenesis and play a critical role in cancer cell growth, proliferation, and survival. Accumulating evidence suggests that they are crucial for the development and the progression of high grade serous ovarian carcinoma (HGSOC). Though many oncogenes have been identified, no successful inhibitors targeting these molecules and their associated pathways are available. This review discusses oncogenes that have been identified recently in HGSOC using different screening strategies. All the genes discussed in this review have been functionally characterized both in vitro and in vivo and some of them are able to transform immortalized ovarian surface epithelial and fallopian tube cells upon overexpression. However, it is necessary to delineate the molecular pathways affected by these oncogenes for the development of therapeutic strategies. Copyright:
© 2020 Manasa et al.

Entities:  

Keywords:  TCGA; copy number alterations; high grade serous adenocarcinoma of the ovary; oncogenes; ovarian cancer

Year:  2020        PMID: 33488950      PMCID: PMC7805537          DOI: 10.18632/genesandcancer.206

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  104 in total

1.  Identification of LMX1B as a novel oncogene in human ovarian cancer.

Authors:  L He; L Guo; V Vathipadiekal; P A Sergent; W B Growdon; D A Engler; B R Rueda; M J Birrer; S Orsulic; G Mohapatra
Journal:  Oncogene       Date:  2013-09-23       Impact factor: 9.867

2.  In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.

Authors:  Michiko Kodama; Takahiro Kodama; Justin Y Newberg; Hiroyuki Katayama; Makoto Kobayashi; Samir M Hanash; Kosuke Yoshihara; Zhubo Wei; Jean C Tien; Roberto Rangel; Kae Hashimoto; Seiji Mabuchi; Kenjiro Sawada; Tadashi Kimura; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-15       Impact factor: 11.205

3.  Notch3 pathway alterations in ovarian cancer.

Authors:  Wei Hu; Tao Liu; Cristina Ivan; Yunjie Sun; Jie Huang; Lingegowda S Mangala; Takahito Miyake; Heather J Dalton; Sunila Pradeep; Rajesh Rupaimoole; Rebecca A Previs; Hee Dong Han; Justin Bottsford-Miller; Behrouz Zand; Yu Kang; Chad V Pecot; Alpa M Nick; Sherry Y Wu; Ju-Seog Lee; Vasudha Sehgal; Prahlad Ram; Jinsong Liu; Susan L Tucker; Gabriel Lopez-Berestein; Keith A Baggerly; Robert L Coleman; Anil K Sood
Journal:  Cancer Res       Date:  2014-04-17       Impact factor: 12.701

4.  Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.

Authors:  Y Wang; Q Sheng; M A Spillman; K Behbakht; H Gu
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

Review 5.  Structure and function of Gab2 and its role in cancer (Review).

Authors:  Chen-Bo Ding; Wei-Na Yu; Ji-Hong Feng; Jun-Min Luo
Journal:  Mol Med Rep       Date:  2015-06-17       Impact factor: 2.952

6.  BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.

Authors:  Zhi-Qiang Wang; Adnen Faddaoui; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Chantal Guillemette; Stéphane Gobeil; Elizabeth Macdonald; Barbara Vanderhyden; Dimcho Bachvarov
Journal:  Oncotarget       Date:  2015-10-13

7.  KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.

Authors:  Zhi-Chuan Zhu; Ji-Wei Liu; Kui Li; Jing Zheng; Zhi-Qi Xiong
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

8.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

9.  Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.

Authors:  Nan Wu; Jia Wei; Yuhui Wang; Jinyan Yan; Ying Qin; Dandan Tong; Bo Pang; Donglin Sun; Haiming Sun; Yang Yu; Wenjing Sun; Xiangning Meng; Chunyu Zhang; Jing Bai; Feng Chen; Jingshu Geng; Ki-Young Lee; Songbin Fu; Yan Jin
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

10.  Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.

Authors:  Laura H Rodgers; Eoghainín Ó hAinmhire; Alexandria N Young; Joanna E Burdette
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.